))
Innovating Epilepsy Treatment: How PRECISIS is Transforming Healthcare Startups with the EASEE System
Manage episode 450100995 series 3417662
Konten disediakan oleh [email protected]. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh [email protected] atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Join Startuprad.io, the authority on the DACH region’s vibrant startup ecosystem, for an exclusive interview with Karl Stoklosa, CEO of PRECISIS, a healthcare startup revolutionizing epilepsy treatment through cutting-edge technology. In this episode, we explore how PRECISIS is leveraging its groundbreaking EASI System—the world’s first minimally invasive brain pacemaker—to improve the lives of epilepsy patients worldwide.
What You’ll Learn in This Episode:
Karl Stoklosa’s Leadership Journey: From an Executive MBA at the University of Chicago Booth School to leading a disruptive healthcare startup, Karl shares insights into his 20+ years of experience in the medical device industry, spanning roles in neuromodulation, cardiac rhythm management, and global healthcare marketing.
The Global Epilepsy Challenge: With 50 million epilepsy patients worldwide and 30% classified as drug-resistant, the need for innovative solutions is critical. Discover how PRECISIS is addressing this gap with the EASI System, providing safer, more effective alternatives to invasive surgeries and medications.
The EASI System’s Impact: Learn about this state-of-the-art neuromodulation device, its minimally invasive design, and its ability to reduce seizures by 50% or more for most patients. With features like manual stimulation for oncoming seizures and MRI compatibility, the EASI System sets a new standard in epilepsy care.
PRECISIS’ European Success: PRECISIS has achieved market approval in key European countries, including Germany, Austria, Switzerland, the UK, and Portugal, and is scaling its commercial operations.
Expansion into the U.S. Market: With FDA breakthrough designation, PRECISIS is preparing for clinical trials in the U.S., showcasing its ambition to become a global leader in medical device innovation.
Call to Action:
Love what you hear? Share this episode, leave us a review, and subscribe to Startuprad.io to stay updated on the latest from the startup ecosystem in Germany, Austria, Switzerland, and beyond!
Explore:
Original Blog Post: https://www.startuprad.io/blog/innovating-epilepsy-treatment-with-precisis-a-healthcare-startup-revolutionizing-technology
Work With Us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
Give Feedback: https://forms.gle/SrcGUpycu26fvMFE9
Follow the Editor-in-Chief: Jörn Menninger on LinkedIn
Special Offer: Startuprad.io listeners can create two free SEO-optimized blog posts per month with ModernIQs.com. Sign up now to claim this exclusive deal!
Interested in Working with us? Have a look here: https://www.startuprad.io/become-a-partner Startuprad.io™ - All Rights Reserved279 episode
Bagikan
